Sars-cov-2-vaccine-inactivated-sinovac-biotech/tozinameran: Subepidermal blistering disease: case report.

A 79-year-old woman developed a rare subepidermal blistering disease after receiving COVID-19 vaccinations. She had received two doses of the Sinovac-CoronaVac vaccine and a booster dose of the Pfizer-BioNTech vaccine. The woman experienced pruritic cutaneous blisters one week after the booster dose. Physical examination showed tense and haemorrhagic blisters, and skin biopsies confirmed the diagnosis of subepidermal blistering disease. Treatment with clobetasol led to improvement, but the lesions recurred after discontinuation and were managed with topical corticosteroids. [Extracted from the article]